Bio-Modeling Systems SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bio-Modeling Systems SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10535
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bio-Modeling Systems SAS (BM Systems) is a biotechnology company that discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as computer-assisted deductive integration (CADI), which is used in the discovery of new medicines and cosmetics. Its CADI platform undertakes contract research and internal research production in the areas of infection-immunology, inflammation, industrial biotechnology, cancer, tissue differentiation, dermatology and matabolism among others. The company caters to several pharmaceutical, cosmetic, biotechnologies, medical devices and diagnostic companies, among others. It provides novel hypotheses discovery and novel therapeutics diagnostics solution. BM Systems is headquartered in Paris, France.

Bio-Modeling Systems SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Bio-Modeling Systems Enters into R&D Agreement with Aepodia 10
BM Systems Enters Into Co-Development Agreement With Persistent Systems For Systems-Based Drug Discovery Solutions 11
Licensing Agreements 12
Theranexus Enters into Licensing Agreement with CEA and Bio-Modeling Systems 12
Bio-Modeling Systems SAS – Key Competitors 13
Bio-Modeling Systems SAS – Key Employees 14
Bio-Modeling Systems SAS – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Key Facts 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Modeling Systems SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bio-Modeling Systems Enters into R&D Agreement with Aepodia 10
BM Systems Enters Into Co-Development Agreement With Persistent Systems For Systems-Based Drug Discovery Solutions 11
Theranexus Enters into Licensing Agreement with CEA and Bio-Modeling Systems 12
Bio-Modeling Systems SAS, Key Competitors 13
Bio-Modeling Systems SAS, Key Employees 14

List of Figures
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bio-Modeling Systems SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Bio-Modeling Systems SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Diploma PLC (DPLM):企業の財務・戦略的SWOT分析
    Summary Diploma PLC (Diploma) is a supplier of technical products and services. The company operates through its business such as life sciences, seals and controls. Its life sciences segment supplies instrumentation, consumables, and related services to the healthcare and environmental industries. D …
  • Snowy Hydro Ltd:電力:M&Aディール及び事業提携情報
    Summary Snowy Hydro Ltd (Snowy Hydro) is an integrated energy utility. It has presence in the energy vertical, from generating energy, providing price risk management products for wholesale customers, and delivering energy to homes and businesses. The company produces electricity from gas, hydro, an …
  • Denator AB:医療機器:M&Aディール及び事業提携情報
    Summary Denator AB (Denator) is a provider of heat stabilization technology solutions that markets, develops, and sells instruments and consumables to address needs in the life science and clinical research markets. The company provides products such as stabilizor peptide extraction kits, stabilizor …
  • Mapletree Logistics Trust Management Ltd:企業の戦略・SWOT・財務情報
    Mapletree Logistics Trust Management Ltd - Strategy, SWOT and Corporate Finance Report Summary Mapletree Logistics Trust Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Johnson Electric Holdings Limited:企業の戦略・SWOT・財務情報
    Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Johnson Electric Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tristan Technologies Inc:企業の製品パイプライン分析
    Summary Tristan Technologies Inc (Tristan) is a medical device company that offers laboratory products. The company designs, develops and manufactures components and systems for biomagnetic measurement and clinical applications. Its products comprise biomagnetic devices, geomagnetic, cryogenic, non- …
  • L&T Finance Holdings Ltd:企業の戦略・SWOT・財務情報
    L&T Finance Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary L&T Finance Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • China Petroleum & Chemical Corp:企業の戦略・SWOT・財務情報
    China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Lululemon Athletica, Inc. (LULU):企業の財務・戦略的SWOT分析
    Lululemon Athletica, Inc. (LULU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • ClubCorp Holdings Inc:企業のM&A・事業提携・投資動向
    ClubCorp Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ClubCorp Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • OpenWay Group:企業の戦略的SWOT分析
    OpenWay Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Assembly Biosciences Inc (ASMB):製薬・医療:M&Aディール及び事業提携情報
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Broadwind Energy, Inc. (BWEN)-エネルギー分野:企業M&A・提携分析
    Summary Broadwind Energy, Inc. (Broadwind) is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. It offers a wide range of products from gears and gearing systems, to wind turbine towers, fabrications and industrial weldments. B …
  • Hess Corp (HES):企業の財務・戦略的SWOT分析
    Hess Corp (HES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provider of drug discovery and development solutions. The company offers functional discovery services such as toxicology models, computational chemistry, medicinal chemistry, structural biology, drug met …
  • Eli Lilly and Co (LLY)-医療機器分野:企業M&A・提携分析
    Summary Eli Lilly and Company (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, critical care, men's health and musculoskeletal problems. It a …
  • TIBCO Software, Inc.:企業のM&A・事業提携・投資動向
    TIBCO Software, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TIBCO Software, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • NH Hotel Group, S. A. (NHH):企業の財務・戦略的SWOT分析
    NH Hotel Group, S. A. (NHH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Specsavers Optical Group Ltd:企業の戦略・SWOT・財務分析
    Specsavers Optical Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Specsavers Optical Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆